Kirkland & Ellis represented Nordic Capital Fund IX in connection with its acquisition of Orchid Orthopedic Solutions from Altor Equity Partners in a transaction announced on January 21, 2019. Orchid, headquartered in Holt, Michigan, is a world leader in designing and manufacturing orthopedic implants with 12 manufacturing sites in the U.S., U.K., Switzerland and China. The proposed transaction is expected to close by the end of the first quarter of 2019.
Read the company press release
The Kirkland team was led by transactional partners Armand Della Monica, Constantine Skarvelis, Andrew Kimball and Adi Herman with associates Charles Wehbe, Blair Baker, Jakob Soerensen and Sharon Skipper. Others on the deal include debt finance partners Jason Kanner and Evgeny Zborovsky, and associates Daniel Amato and Kanesh Balasubramaniam, healthcare regulatory partner Dennis Williams and associate Phillip DeFedele, tax partners Mike Beinus and Ryan Roberts, technology and IP transactions partners Edward Sadtler and Jenny Wilson, and associates Daisy Darvall, Ashley Eisenberg and Joanna Schlingbaum, executive compensation partners Mike Krasnovsky and Kate Coverdale and associate Galen Spielman, employee benefits partner Robert Zitko, environmental partner Toby Chun and associate Aaron Newell, labor partners Matthew Keiser and Melissa Soares, antitrust and competition partners Carla Hine and Paula Riedel and associate David Riley, international trade partner Mario Mancuso and associates Joshua Thompson and Jeremy Iloulian, and real estate partner Jennifer Sheehan.